ESSA Pharma Stock Price - EPIX

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
ESSA Pharma Inc EPIX NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.07 1.22% 5.80 5.8352 5.60 5.70 5.73 16:30:00
Bid Price Ask Price Spread Spread % News
2.07 7.29 5.22 71.6% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
50 18,237 $ 5.69 $ 103,760 32,655 1.41 - 6.1372
Last Trade Time Type Quantity Stock Price Currency
16:00:00 800 $ 5.80 USD

ESSA Pharma Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 120.42M 20.76M $ -11.63M - - 20.82M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

ESSA Pharma News

Loading Messages....

Latest EPIX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EPIX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week5.845.945.605.7129,785-0.04-0.68%
1 Month5.475.945.005.6621,9130.336.03%
3 Months4.696.13723.77095.0939,5571.1123.67%
6 Months2.886.13721.413.8239,0472.92101.39%
1 Year4.186.13721.413.6923,9961.6238.76%
3 Years1.956.13720.101.0355,1543.85197.44%
5 Years8.3011.690.101.1441,727-2.50-30.12%

ESSA Pharma Description

ESSA Pharma Inc is a pharmaceutical company. The company is in preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs which selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.


Your Recent History
NASDAQ
EPIX
ESSA Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.